das Chagas Pablo Ferreira, de Sousa Graziella Ribeiro, Kodama Márcio Hideki, de Biagi Junior Carlos Alberto Oliveira, Yunes José Andres, Brandalise Silvia Regina, Calin George Adrian, Tone Luiz Gonzaga, Scrideli Carlos Alberto, de Oliveira Jaqueline Carvalho
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil; Universidade Federal de Alfenas (UNIFAL), Alfenas, MG, Brazil.
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil.
Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):28-34. doi: 10.1016/j.htct.2019.12.003. Epub 2020 Jan 30.
Aberrant expression of long non-coding RNAs (lncRNAs) has been detected in several types of cancer, including acute lymphoblastic leukemia (ALL), but lncRNA mapped on transcribed ultraconserved regions (T-UCRs) are little explored. The T-UCRs uc.112, uc.122, uc.160 and uc.262 were evaluated by quantitative real-time PCR in bone marrow samples from children with T-ALL (n=32) and common-ALL/pre-B ALL (n=30). In pediatric ALL, higher expression levels of uc.112 were found in patients with T-ALL, compared to patients with B-ALL. T-cells did not differ significantly from B-cells regarding uc.112 expression in non-tumor precursors from public data. Additionally, among B-ALL patients, uc.112 was also found to be increased in patients with hyperdiploidy, compared to other karyotype results. The uc.122, uc.160, and uc.262 were not associated with biological or clinical features. These findings suggest a potential role of uc.112 in pediatric ALL and emphasize the need for further investigation of T-UCR in pediatric ALL.
在包括急性淋巴细胞白血病(ALL)在内的多种癌症中均检测到长链非编码RNA(lncRNA)的异常表达,但对映射于转录超保守区域(T-UCR)的lncRNA研究较少。通过定量实时PCR对32例T-ALL患儿和30例普通ALL/pre-B ALL患儿骨髓样本中的T-UCRs uc.112、uc.122、uc.160和uc.262进行了评估。在小儿ALL中,与B-ALL患儿相比,T-ALL患儿中uc.112的表达水平更高。从公开数据来看,在非肿瘤前体细胞中,T细胞与B细胞在uc.112表达方面无显著差异。此外,在B-ALL患儿中,与其他核型结果相比,超二倍体患儿中uc.112也有所增加。uc.122、uc.160和uc.262与生物学或临床特征无关。这些发现提示uc.112在小儿ALL中可能发挥作用,并强调有必要对小儿ALL中的T-UCR进行进一步研究。